Key result
A pharmacoinvasive approach using thrombolytic therapy followed by transcutaneous coronary intervention is an effective strategy for acute STEMI when primary PCI is delayed.
Why the study?
Logistic and infrastructure issues can hamper timely primary PCI for acute STEMI, making a pharmacoinvasive strategy necessary for early recovery of coronary perfusion.
Is a pharmacoinvasive approach effective for the treatment of acute ST-segment elevation myocardial infarction when primary PCI is delayed?
Is a pharmacoinvasive approach effective for the treatment of acute ST-segment elevation myocardial infarction when primary PCI is delayed?
A pharmacoinvasive strategy using thrombolytics like recombinant prourokinase followed by PCI is an effective alternative for STEMI patients when primary PCI cannot be performed timely.
Supports pharmacoinvasive strategy for STEMI when timely primary PCI is unavailable; extends evidence for alternative reperfusion in logistical constraints.
The articled focused on the pharmacoinvasive approach to the treatment of acute ST-segment elevation myocardial infarction. Current guidelines prioritize the primary transcutaneous coronary intervention. However, in both the Russian Federation and other countries, there are some peculiarities (logistic issues, specific aspects of infrastructure of medical facilities), which may hamper timely conduction of the endovascular treatment. In such cases, the thrombolytic therapy subsequently supplemented with transcutaneous coronary intervention would appear the most effective strategy aimed at the earliest recovery of coronary perfusion. The authors provided results of major studies that used such approach and the effect of using the thrombolytic therapy with recombinant prourokinase, a Russian third generation thrombolytic drug.
No takes yet. Share an insight, caveat, or question.
Milenkina et al. (2020) conducted a review in Acute ST-segment elevation myocardial infarction. Pharmacoinvasive approach (thrombolytic therapy followed by transcutaneous coronary intervention) was evaluated. A pharmacoinvasive approach using thrombolytic therapy followed by transcutaneous coronary intervention is an effective strategy for acute STEMI when primary PCI is delayed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: